Omvärldsfaktorer påverkar marginalen negativt i Q1'22 Nettoomsättningen i Q1’22 uppgick till 81,5 mk...
Redeye comments on Remedy’s Q1 business review. Revenue was EUR 1.
Today, Zinzino published its interim report for the first quarter of 2022.
Announces potenial tap issue of SEK 200m In dialogue with several potential acquisition targets… …wh...
Eurocon levererar ytterligare ett imponerande kvartal.
Redeye comments on Ultimovacs’ Q1 report; with patient recruitment for the company’s phase II trials...
Lipigon har fått godkänt av Läkemedelsverket att starta kliniska studier och under 2022 väntar vikti...
Q1 sales -15% vs. ABG, EBITA margin 3% vs. ABG 12% Consensus estimates to come down Conference call ...
Redeye comments on Safello’s Q1 report, which deviated somewhat on net revenue but was more or less ...
Adj. EBITA SEK 13.5m, 22% above ABGSCe Estimates up ~10% on est.
Marimekko came in strong with Q1 net sales as well as EBIT growing rapidly.
6% sales and 20% EBITA beat vs ABGSCe in Q1 Guidance intact: “2022 adj.
TCECUR har inlett året starkt där Q1-rapporten visade den näst högsta försäljningen för ett enskilt ...
Odinwell har nått avgörande delmål i teknikutvecklingen och valideringsstudier ska inledas.
Relais reported Q1 results that were well below Refinitiv consensus.
Ferronordic delivered a decent Q1 report with earnings significantly stronger than expected (EBIT 41...
Q1 slightly below expectations, sales -8% vs ABGSCe We cut ‘23e and ‘24e EBITDA by 29% and 21% Share...
Company activities Studentbostäder I Norden has a vision to provide sustainable housing for student...
Q1-rapport Ascelia presenterade under gårdagen sin rapport för det första kvartalet.
Kostnadsuppgång i Q1 Nettoomsättningen minskade under Q1 2022 till 0,5 mkr (9,9), där skillnaden huv...
